2008 News

The Ohio State University College of Pharmacy Appoints Therigy Executive to
the Dean's Corporate Council

ORLANDO, Fla. (January 1, 2008) - Russel R. Allinson, RPh., MS co-founder and chief clinical officer of Therigy Corporation, the healthcare industry's leading source of advisory and consulting services related to specialty pharmacy and pharmaceuticals, has been appointed to a two-year term on the prestigious Corporate Council of The Ohio State University College of Pharmacy.

Robert W. Brueggemeier, Ph.D., professor of medical chemistry and dean of the College of Pharmacy, said the Corporate Council was established in 1994 to provide interaction between academia and corporate entities to deal with the challenges and opportunities of healthcare.

"I am excited to welcome Russ Allinson to the Corporate Council. His professional experiences and background will bring a new dimension to the types of industry and expertise represented on the Council," Brueggemeier said.

Allison said he is honored by the appointment.

"Therigy Inc. has been working to close the gap between state-of-the-art pharmacological research and practical applications in the healthcare arena," said Allison. "The Corporate Council represents a great learning opportunity for us, and a chance to contribute to one of the most critical issues that face this country's healthcare system today," he said.

The Corporate Council's new chair is Dr. Mark Sirgo, president and chief executive officer of BioDelivery Sciences International (Nasdaq:BDSI)

For more information, contact:

Robert W. Brueggemeier, Ph.D., Dean, College of Pharmacy, Ohio State University, 614-292-5711

Lilian Myers, Marketing Director, Therigy Corporation 407.992.8753 Lilian.myers@therigy.com

Larry Vershel or Beth Payan, Larry Vershel Communications Inc. 407-644-4142 lvershelco@aol.com

About Therigy
For those who invest in, manufacture, dispense, pay for, and administer specialty pharmaceuticals, Therigy is the healthcare industry's trusted source for rapidly changing business, clinical, and operational intelligence as well as vital advisory and consulting services that assure appropriate use and optimal outcomes. Therigy's well-known experts track and report on industry advances delivered through subscriptions as well as providing hands-on engagement to assist organizations in operational evaluation and optimization, planning and development of best-practices and clinical protocols, or a variety of other specialized research and analysis. Therigy clients include Cigna, McKesson, Cardinal, Precision Rx, Prime Therapeutics, and many others.

 

www.ucf.edu